Objective
Venous to arterial carbon dioxide difference (AVCO2) correlates with cardiac output (CO) in critically ill adults, but its utility in pediatric patients is unclear. We sought to correlate AVCO2 with other CO surrogates (arteriovenous oxygen saturation difference [AVO2], central venous oxygen saturation [ScVO2], and lactate); as well as investigate its capacity to predict poor outcomes associated with low cardiac output (LCOS) in infants after cardiac surgery with cardiopulmonary bypass (CPB).
Design
Retrospective chart review. Poor outcome was defined as any: inotrope score > 15; death, cardiac arrest, ECMO, unplanned surgical re-intervention.
Setting
Pediatric cardiovascular intensive care unit
Patients
139 infants <90d who underwent CPB, from October 2012 to May 2015.
Measurement and Main Results
296 arterial and venous blood gas pairs from admission (n=139), 6hrs (n=62), 12hrs (n=73), 24hrs (n=22) were included in analysis. For all pairs, AVCO2 was moderately correlated with AVO2 (R2= 0.53, p<0.01) and ScVO2 (R2= −0.43, p<0.01), but not lactate. On admission AVCO2 was also moderately correlated with ScVO2 (R2= 0.-0.40, p<0.01) and AVO2 (R2= 0.55, p<0.01), but not lactate. 34/139 neonates (24.5%) had poor outcome. Median admission AVCO2 was 5.9 mm Hg (3.8, 9.2). Patients with poor outcome had median admission AVCO2 8.3 mmHg (5.6, 14.9) vs. 5.4 (3.0, 8.4) in those without poor outcome. AVCO2 (AUC=0.69, p<0.01), serum lactate (AUC=0.64, p=0.02) and ScVO2 (AUC=0.74, p<0.01) were predictive of poor outcome. After controlling for covariates, admission AVCO2 remained significantly associated with poor outcome [OR 1.3, 95% CI: 1.1–1.45], including independent association with mortality, [OR 1.2 (95% CI 1.07–1.31)].
Conclusions
AVCO2 is correlated with important surrogates of CO, and is associated with poor outcome and mortality related to LCOS after cardiac surgery in infants. Prospective validation of these findings, including confirmation that AVCO2 can identify LCOS in real-time is warranted.